Towards an ideal neonatal sepsis screen panel - A review

  • Karthikeyan Gengaimuthu
  • Vaishni Karthikeyan
Keywords: cell surface markers, C-reactive protein, neonate, procalcitonin, sepsis screening

Abstract

Neonatal sepsis is an important determinant of survival in the neonatal units. Early recognition and institution of
antibiotic therapy is the key for successful treatment. Complete blood count and C-reactive protein are the ritualistic
commonly used tests that aid the clinician in the initiation and stopping of antibiotic therapy. Procalcitonin at 24 h
is useful in diagnosing early-onset neonatal sepsis (EOS). Interleukin 6 and CD 11β for EOS and CD 64 for late-onset
sepsis are promising candidates for future sepsis screen panel as logistical issues like the cost factor rule out their routine
use currently. We summarize the current available evidence on the use of these laboratory markers and the clinical sepsis
score and suggest a practical guide for antibiotic therapy (initiation and duration of treatment) for the benefit of practicing
pediatricians.

Published
2017-11-22
How to Cite
Gengaimuthu, K., & Karthikeyan, V. (2017, November 22). Towards an ideal neonatal sepsis screen panel - A review. Indian Journal of Child Health, 4(4), 614-618. Retrieved from http://atharvapub.net/index.php/IJCH/article/view/377
Section
Clinical Practice